Pyrophosphoric Acid

Pyrophosphoric Acid

SCHEMBL28023253

Clc1ccc2ccccc2n1.O=P(O)(O)OP(=O)(O)O

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 8/20 0.42
NPC1 O15118 7/20 0.42
SMN1; SMN2 Q16637 4/20 0.41
NFKB1 P19838 2/20 0.41
NFKB2 Q00653 2/20 0.41
RELA Q04206 2/20 0.41
NCF1 P14598 1/20 0.41
NOS2 P35228 1/20 0.41
BACE1 P56817 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
CNR2 P34972 2/20 0.41
MGAM O43451 1/20 0.41
ALDH1A1 P00352 3/20 0.40
MAPT P10636 2/20 0.40
GAA P10253 1/20 0.40
AR P10275 1/20 0.39
TP53 P04637 2/20 0.38
KDM4E B2RXH2 1/20 0.38
TSHR P16473 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL28023255 0.89 NCF1 (0.47) RAB9ANPC1SMN1; SMN2NFKB1NFKB2
Phosphoric Acid SCHEMBL29119725 0.89 NCF1 (0.47) RAB9ANPC1SMN1; SMN2NFKB1NFKB2
SCHEMBL30168988 0.81 NCF1 (0.58) RAB9ANPC1SMN1; SMN2NCF1NOS2
SCHEMBL14127304 0.81 NCF1 (0.58) RAB9ANPC1SMN1; SMN2NCF1NOS2
SCHEMBL7252 0.81 NCF1 (0.58) RAB9ANPC1SMN1; SMN2NCF1NOS2
SCHEMBL28744150 0.79 NCF1 (0.56) RAB9ANPC1SMN1; SMN2NCF1NOS2
SCHEMBL7429726 0.79 NCF1 (0.56) RAB9ANPC1SMN1; SMN2NCF1NOS2
Hydrochloric Acid SCHEMBL3651493 0.79 NCF1 (0.56) RAB9ANPC1SMN1; SMN2NCF1NOS2
SCHEMBL28276998 0.79 NCF1 (0.56) RAB9ANPC1SMN1; SMN2NCF1NOS2
Ammonia Solution, Strong SCHEMBL28019947 0.79 NCF1 (0.56) RAB9ANPC1SMN1; SMN2NCF1NOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105362231-A Method for manufacturing sustained-release delivery carrier lipid nanoparticles with different Log P values UNIV OF MALAYA 2016-03-02 CN disclosed
CN-102482286-B Novel 1,2,3, 4-tetrahydropyrimidino {1,2-a } pyrimidin-6-one derivatives, their preparation and their medical use SANOFI SA 2015-07-15 CN disclosed
CN-102482285-B Novel 2,3-dihydro-1h-imidazo(1,2-a)pyrimidin-5-one derivatives, preparation thereof, and pharmaceutical use thereof SANOFI SA 2015-07-15 CN disclosed